AtriCure

Mason, United States Founded: 2000 • Age: 26 yrs Listed
Cardiac ablation and occlusion devices for atrial fibrillation are provided.

About AtriCure

AtriCure is a publicly listed company based in Mason (United States) founded in 2000. Cardiac ablation and occlusion devices for atrial fibrillation are provided. The company has 1,300 employees. AtriCure has completed 4 acquisitions, including Estech, SentreHEART and nContact. Its website atricure.com draws about 18 thousand monthly visits. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Similar companies include AtaCor Medical, Kestra Medical Technologies and CardioFocus; 3 of its 3 listed similar companies have raised funding.

Company details

AtriCure was founded in 2000 and is headquartered in Mason, United States. Products focused on cardiac surgery, such as ablation devices, left atrial appendage occlusion tools, and intraoperative testing equipment, are offered in the medical device sector. The company was taken public in 2005. In October 2015, nContact, a developer of ablation solutions, was acquired to expand capabilities. Operations center on therapies for atrial fibrillation.

Key Metrics
  • Annual Revenue
    $534.53 M (USD)
    14.88
    as on Dec 31, 2025
  • Net Profit
    -$11.45 M (USD)
    74.39
    as on Dec 31, 2025
  • EBITDA
    $17.08 M (USD)
    as on Dec 31, 2025
  • Employee Count
    1,300
  • Investments & Acquisitions
    Estech

    & 3 more

Apps and channels of AtriCure

its YouTube channel AtriCure, Inc. has 1.17K subscribers and 30 videos.

AtriCure, Inc.
YouTube 1.17K subscribers 30 videos Science & Technology
Open channel

Videos from AtriCure

The most watched videos on AtriCure's YouTube channel, AtriCure, Inc. (1.17K subscribers). Click a video to play it here.

AtriCure Patient Atrial Fibrillation Animation
1.4K views
AtriClip PRO2® Device Animation: Mini AVR Procedure with LAA Occlusion
1.3K views
Blake’s Pectus Excavatum Full Journey
971 views
AtriClip FLEX∙V® Device Animation
776 views

More on AtriCure, Inc..

People of AtriCure

161 people are tracked at AtriCure (70 in leadership, 8 in board & advisors, 83 in team); the tracked headcount is 1,300.

NameRoleGroup
Angela L. Wirick
Chief Financial OfficerLeadership
Douglas J. Seith
Chief Operating OfficerLeadership
Karl Dahlquist
Chief Legal OfficerLeadership
Sam Privitera
Chief Technical OfficerLeadership
A K Masud
Vice President, Asia Pacific And Greater ChinaLeadership
Doug Seith
Chief Operating OfficerLeadership
Wendy Trevil
Senior Director, Diversity, Equity And InclusionLeadership
Rebecca Anderson
Senior Director Product MarketingLeadership
Tim McGill
Sr. Director Of Marketing, Left Atrial Appendage ManagementLeadership
Michael H. Carrel
President And Chief Executive OfficerLeadership
Pete Schweikle
Senior Director GSSLeadership
Paul Ahlemeyer
Senior Director Of MarketingLeadership
Matt Halasy
Director Of Global Sales PlanningLeadership
Craig Sander
Principal Talent Development PartnerLeadership
Justin Noznesky
Chief Marketing & Strategy OfficerLeadership
Vini Doraiswamy
Chief Scientific OfficerLeadership
Michael Balger
Vice President Of Sales | Cryo Nerve BlockLeadership
Gina Martin
Sr. Director Sales Support, U.s. Asia And AmericasLeadership
Barrett Ethridge
Area Director - Hybrid Therapies SouthwestLeadership
Elizabeth Barnes
Senior Director, R&dLeadership

141 more people are available in the full profile.

Premium access

Complete people profiles for AtriCure

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of AtriCure

AtriCure is a publicly listed company on the NASDAQ with ticker symbol ATRC in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date05 Aug 2005
  • Listed onNASDAQ: ATRC
  • Listed entityAtriCure, Inc.
  • Exchange sectorHealth technology
  • ISINUS04963C2098
  • Share price$56.87 (-0.72% on the day) · 2026-10-13
  • Market capitalisation$2.89B
  • Price to earnings262.7
  • EPS (diluted, trailing year)$0.22
  • Volume (last session)596,098

Financials of AtriCure

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$534.5M-$11.4M$17.1M
2024$465.3M-$44.7M-$9.3M
2023$399.2M-$30.4M-$16.3M
2022$330.4M-$46.5M-$31.0M
2021$274.3M$50.2M-$36.9M
Premium access

Detailed financial statements for AtriCure

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by AtriCure

AtriCure has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Estech, SentreHEART and nContact.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Suture-based devices for soft tissue closure are developed.
sentreheart.comRedwood, United States2005Aug 2019••••
Cardiac ablation devices for atrial fibrillation treatment are developed.
ncontactsurgical.comMorrisville, United States2005Oct 2015$99M
Epicardial ablation devices
ncontact.usMorrisville, United States2005Oct 2015••••
RF ablation devices for atrial fibrillation treatment are provided.
estech.comSan Ramon, United States1996Dec 2013••••
Premium access

Complete acquisition details for AtriCure

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of AtriCure

6 dated milestones of AtriCure across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded AtriCure is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Estech.
  4. Acquisition Acquires nContact.
  5. Acquisition Acquires nContact Surgical.
  6. Acquisition Acquires SentreHEART.

Similar companies to AtriCure

AtriCure has 3 listed similar companies in our database, 3 of them funded. They include AtaCor Medical, Kestra Medical Technologies and CardioFocus.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
atacor.com2014San Clemente, United States$136.8M15
An implantable pacemaker system is developed for cardiac pacing therapy.
kestramedical.com2014Kirkland, United States$196M118
Medical devices are developed to support cardiovascular patients at risk.
cardiofocus.com1990Marlborough, United States$260.86M105
Endoscopic catheter for atrial fibrillation ablation is developed.
Premium access

Detailed similar companies of AtriCure

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of AtriCure

The website of AtriCure (atricure.com) receives about 18.2K visits a month.

  • Monthly visits
    18.2K

    ▼ 9.4% vs previous month

Similar websites

Websites whose visitors overlap most with AtriCure. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
medtronic.com
100%
2.6M#22,622View details
sjm.com
99%
1.2K#13,629,967View details
cardiokinetix.com
83%
View details
arrowintl.com
74%
View details
sorin.com
74%
View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 24 similar websites and full traffic analytics for AtriCure

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 24 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as AtriCure (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Atricure

Premium access

Complete news archive for AtriCure

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AtriCure

AtriCure was founded in 2000.

AtriCure is headquartered in Mason, United States. It is registered at Mason, Ohio, United States.

AtriCure has 1,300 employees.

Annual revenue of AtriCure is $534.53M as on Dec 31, 2025.

AtriCure was founded in 2000 and is headquartered in Mason, United States. Products focused on cardiac surgery, such as ablation devices, left atrial appendage occlusion tools, and intraoperative testing equipment, are offered in the medical device sector. The company was taken public in 2005. In October 2015, nContact, a developer of ablation solutions, was acquired to expand capabilities. Operations center on therapies for atrial fibrillation.

AtriCure's top competitors include AtaCor Medical, CardioFocus and Kestra Medical Technologies.

Yes, AtriCure is publicly traded on NASDAQ under the ticker symbol ATRC.

AtriCure has made 4 acquisitions, including Estech, SentreHEART, and nContact.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available